CompuGroup Medical Successfully Concludes Share Buyback Program

CompuGroup Medical SE & Co. KGaA announced the successful completion of its share buyback program on April 26, just before the planned end date. The program, initiated on March 25, 2024, aimed to acquire up to 500,000 shares. By the closing, the company purchased shares totaling a volume of EUR 14.6 million, utilizing nearly the full amount earmarked for the buyback of up to EUR 15.5 million.

The operation secured around 0.93% of CompuGroup Medical's total share capital, with a weighted average price per share set at EUR 29.26. This strategic move demonstrates the firm's commitment to bolster shareholder value and confidence in its financial health and future prospects.

All transactions were conducted through the XETRA platform of the Frankfurt Stock Exchange, facilitated by an appointed bank. The acquired shares provide flexibility for future strategic actions, as authorized by the company's annual general meeting in May 2021.